1. Healey J, Lane J. Chordoma: a critical review of diagnosis and treatment. The Orthopedic clinics of North America. 1989; 20(3):417-26.
2. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973– 1995. Cancer Causes & Control. 2001;12(1):1-11.
3. Weber AL, Brown EW, Hug EB, Liebsch NJ. Cartilaginous tumors and chordomas of the cranial base. Otolaryngologic clinics of North America. 1995; 28(3):453-71.
4. Perzin KH, Pushparaj N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: A clinicopathologic study. XIV: Chordomas. Cancer. 1986; 57(4):784-96.
5. Wold LE, Laws ER. Cranial chordomas in children and young adults. Journal of neurosurgery. 1983; 59(6):1043-7.
6. Horten BC, Montague SR. In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems. Acta neuropathologica. 1976; 35(1):13-25.
7. Stark AM, Mehdorn HM. Chondroid clival chordoma. New England Journal of Medicine. 2003; 349(10):e10.
8. Kitai R, Yoshida K, Kubota T, Sato K, Handa Y, Kasahara K, et al. Clival chordoma manifesting as nasal bleeding. A case report. Neuroradiology. 2005; 47(5):368-71.
9. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, MeisâKindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2000; 88(9):2122-34.
10. Walcott BP, Nahed BV, Mohyeldin A, Coumans J-V, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. The lancet oncology. 2012; 13(2):e69-e76.
11. Santegoeds RG, Temel Y, Beckervordersandforth JC, Van Overbeeke JJ, Hoeberigs CM. State-of-the-art imaging in human chordoma of the skull base. Current radiology reports. 2018; 6(5):16.
12. Rossleigh MA, Smith J, Yeh S. Scintigraphic features of primary sacral tumors. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 1986; 27(5):627-30.
13. Kaiser TE, Pritchard DJ, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984; 53(11):2574-8.
14. Yonemoto T, Tatezaki Si, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1999; 85(4):878-83.
15. Boriani S, Chevalley F, Weinstein JN, Biagini R, Campanacci L, De Iure F, et al. Chordoma of the spine above the sacrum: treatment and outcome in 21 cases. Spine. 1996; 21(13):1569-77.
16. Wu Z, Zhang J, Zhang L, Jia G, Tang J, Wang L, et al. Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas—106 cases review in one institution. Neurosurgical review. 2010; 33(4):451-6.
17. Stacchiotti S, Casali PG, Vullo SL, Mariani L, Palassini E, Mercuri M, et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Annals of surgical oncology. 2010; 17(1):211-9.
18. Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurgical focus. 2003; 15(2):1-5.
19. Kamaleshwaran K, Bhattacharya A, Harisankar C, Goni V, Mittal B. Sacrococcygeal chordoma: Increased 99m Tc methylene diphosphonate uptake on single photon emission computed tomography/computed tomography bone scintigraphy. Indian Journal of Nuclear Medicine: IJNM. 2012; 27(3):199.
20. Rohatgi S, Ramaiya NH, Jagannathan JP, Howard SA, Shinagare AB, Krajewski KM. Metastatic chordoma: report of the two cases and review of the literature. The Eurasian journal of medicine. 2015; 47(2):151.